Search
Creative Medical Technology Holdings Inc
CELZAdd to Watchlist
1.210USD
-0.060-4.72%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.47MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Creative Medical Technology Holdings Inc is 8.00, ranking 167 out of 387 in the Biotechnology & Medical Research industry. The average price target is 20.00, with a high of 20.00 and a low of 20.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
20.000
Target Price
+809.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Creative Medical Technology Holdings Inc
CELZ
1
Beigene Ltd
ONC
27
Ionis Pharmaceuticals Inc
IONS
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Creative Medical Technology Holdings Inc's price target?
Analysts forecast that Creative Medical Technology Holdings Inc's price target is USD 20.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 20.00.
How have Creative Medical Technology Holdings IncCELZ's recent earnings per share performed?
The market expectation was USD -0.38, while Creative Medical Technology Holdings IncCELZ's earnings per share (EPS) for the previous quarter was USD -0.70. EPS for the next quarter is expected at USD -0.39.
What is the analyst rating for Creative Medical Technology Holdings Inc?
Based on the ratings of Creative Medical Technology Holdings Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.